Ultragenyx Pharmaceutical Market Cap

Ultragenyx Pharmaceutical has a market cap or net worth of 2.75 billion as of May 2, 2025. Its market cap has decreased by -1.71% in one year.

Market Cap

2.75B

Enterprise Value

2.88B

Revenue

447.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

38.92

Market Cap Chart

Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from 746.36M to 2.75B, an increase of 268.94%. That is a compound annual growth rate of 12.30%.

Market Cap History

Date	Market Cap	% Change
May 1, 2025	2.75B	-11.20%
Dec 31, 2024	3.10B	0.60%
Dec 29, 2023	3.08B	14.35%
Dec 30, 2022	2.70B	-36.32%
Dec 31, 2021	4.23B	-36.89%
Dec 31, 2020	6.71B	260.04%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	164.49B
Shell	146.70B
HSBC Holdings	144.54B
Unilever	117.94B
Rio Tinto Group	76.59B
RELX PLC	74.87B
British American Tobacco p.l.c.	70.98B
Rolls-Royce Holdings	63.11B

Market Cap Rankings